Back to Results
First PageMeta Content
Immunotherapy / Cancer vaccines / Cancer immunotherapy / Prostate cancer / Vaccine / Gustav Gaudernack / Dendreon / Medicine / Vaccination / Immunology


Document Date: 2014-07-07 03:17:36

Open Document

File Size: 74,20 KB

Share Result on Facebook

City

TÜBINGEN / /

Company

CureVac / Sanofi / Janssen Pharmaceuticals / Media Contacts Dr. Martina Schwarzkopf Russo Partners / /

Country

Germany / /

/

Event

FDA Phase / Product Release / Business Partnership / /

Facility

Cancer Research Institute / /

IndustryTerm

stage biopharmaceutical / technology platforms / Prostate Cancer Treatment / /

MedicalCondition

advanced prostate cancer / cancer / novel cancer / minimally symptomatic metastatic castration-resistant prostate cancer / non-small cell lung cancer / infectious diseases / prostate cancer / /

MedicalTreatment

immunotherapies / vaccination / chemotherapy / immunotherapy / /

Organization

Cancer Research Institute / /

Person

Ingmar Hoerr / Verena Lauterbach / Ludwig Cancer / Arnulf Stenzl / /

/

Position

Governor / principal investigator / Manager Communications CureVac GmbH / chief executive officer / /

Product

RNActive / Harman On Time Radio / CV9104 / RNActive® / /

ProvinceOrState

New York / /

Technology

chemotherapy / /

URL

http /

SocialTag